BioNano Genomics, Inc. Company Profile

08:43 EDT 20th September 2018 | BioPortfolio

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company’s nanoAnalyzer platform provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by grants from genomics programs at agencies, including the NIH and NIST-ATP.

News Articles [345 Associated News Articles listed on BioPortfolio]

IPO Roundup: Bionano Genomics, Megalith Financial Acquisition and Tenzing Acquisition to tap the capital markets

Bionano Genomics plans to raise around US$16mln to boost its presence as a life sciences instrumentation company in the genome analysis space

Genoox & Bionano Partner to Detect Disease-Causing Structural Variants

Genoox, a genetic data analysis company, recently partnered with Bionano Genomics to better identify the nearly 20k potentially disease-causing SVs in the human genome. By combining Genoox technology ...

Bionano Genomics raises $20.6M in IPO

Bionano Genomics Proposes Terms For IPO

Genoox Collaborates with Bionano to Enhance the Detection of Disease Causing Structural Variants in DNA

The Genoox Integrated Platform is Designed to Offer Solutions for Combining Genoox Technology for Aligning and Calling NGS Short-Reads with Bionano Genome Mapping Technology to Be...

Bionano IPO: Novartis Sold Its Stake, And It Seems Expensive

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Drugs and Medications [0 Results]


Clinical Trials [87 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

Companies [407 Associated Companies listed on BioPortfolio]

BioNano Genomics, Inc.

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company’s nanoAnalyzer platform ...

BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company’s nanoAnalyzer platform ...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

More Information about "BioNano Genomics, Inc." on BioPortfolio

We have published hundreds of BioNano Genomics, Inc. news stories on BioPortfolio along with dozens of BioNano Genomics, Inc. Clinical Trials and PubMed Articles about BioNano Genomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioNano Genomics, Inc. Companies in our database. You can also find out about relevant BioNano Genomics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record